Role of methylglyoxal in alzheimer's disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Angeloni, Cristina ^a   Zambonin, Laura ^a   Hrelia, Silvana ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; METHYLGLYOXAL; REACTIVE OXYGEN METABOLITE; AMYLOID BETA PROTEIN; ANTIOXIDANT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; TAU PROTEIN;

ALZHEIMER DISEASE; CELL METABOLISM; GLYCATION; HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRECURSOR; PROTEIN CROSS LINKING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; PC12 CELL LINE; PHOSPHORYLATION; RAT; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; GLYCOGEN SYNTHASE KINASE 3; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PC12 CELLS; PHOSPHORYLATION; PYRUVALDEHYDE; RATS; RISK FACTORS; TAU PROTEINS;

EID: 84897568346     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/238485     Document Type: Review

References (167)

1. Zheng H., Koo E. H., Biology and pathophysiology of the amyloid precursor protein. Molecular Neurodegeneration 2011 6 1, article 27 2-s2.0-79955128215 10.1186/1750-1326-6-27
2. Walsh D. M., Klyubin I., Fadeeva J. V., Rowan M. J., Selkoe D. J., Amyloid- β oligomers: their production, toxicity and therapeutic inhibition. Biochemical Society Transactions 2002 30 4 552 557 2-s2.0-0036669881 10.1042/BST0300552 (Pubitemid 35001597)
3. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., Cotman C. W., Apoptosis is induced by β -amyloid in cultured central nervous system neurons. Proceedings of the National Academy of Sciences of the United States of America 1993 90 17 7951 7955 2-s2.0-0027257708 (Pubitemid 23260832)
4. Bulteau A.-L., Verbeke P., Petropoulos I., Chaffotte A.-F., Friguet B., Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro. The Journal of Biological Chemistry 2001 276 49 45662 45668 2-s2.0-0035824663 10.1074/jbc.M105374200
5. Sachdev P. S., Zhuang L., Braidy N., Wen W., Is Alzheimer's a disease of the white matter? Current Opinion in Psychiatry 2013 26 3 244 251 10.1097/YCO.0b013e32835ed6e8
6. Cleveland D. W., Hwo S. Y., Kirschner M. W., Purification of tau, a microtubule associated protein that induces assembly of microtubules from purified tubulin. Journal of Molecular Biology 1977 116 2 207 225 2-s2.0-0017649032 (Pubitemid 8215104)
7. Brandt R., Lee G., Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro. The Journal of Biological Chemistry 1993 268 5 3414 3419 2-s2.0-0027406644 (Pubitemid 23070977)
8. Münch G., Thome J., Foley P., Schinzel R., Riederer P., Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Research Reviews 1997 23 1-2 134 143 2-s2.0-0343554069 10.1016/S0165-0173(96)00016-1 (Pubitemid 27090752)
9. Ulrich P., Cerami A., Protein glycation, diabetes, and aging. Recent Progress in Hormone Research 2001 56 1 21 2-s2.0-0035787070 10.1210/rp.56.1.1 (Pubitemid 36068052)
10. Thornalley P. J., Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy. General Pharmacology 1996 27 4 565 573 2-s2.0-0030176306 10.1016/0306-3623(95)02054-3 (Pubitemid 26233322)
11. Thornalley P. J., Dicarbonyl intermediates in the Maillard reaction. Annals of the New York Academy of Sciences 2005 1043 111 117 2-s2.0-23744447530 10.1196/annals.1333.014 (Pubitemid 41123896)
12. Ramasamy R., Vannucci S. J., Yan S. S. D., Herold K., Yan S. F., Schmidt A. M., Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005 15 7 16R 28R 2-s2.0-26444478269 10.1093/glycob/cwi053 (Pubitemid 41417992)
13. Chen K., Maley J., Yu P. H., Potential implications of endogenous aldehydes in β -amyloid misfolding, oligomerization and fibrillogenesis. Journal of Neurochemistry 2006 99 5 1413 1424 2-s2.0-33750899858 10.1111/j.1471-4159.2006.04181.x (Pubitemid 44730095)
14. Fawver J. N., Schall H. E., Chapa R. D. P., Zhu X., Murray I. V., Amyloid-beta metabolite sensing: biochemical linking of glycation modification and misfolding. Journal of Alzheimer's Disease 2012 30 1 63 73 10.3233/JAD-2012-112114
15. Castellani R. J., Harris P. L. R., Sayre L. M., Fujii J., Taniguchi N., Vitek M. P., Founds H., Atwood C. S., Perry G., Smith M. A., Active glycation in neurofibrillary pathology of Alzheimer disease: N ε -(Carboxymethyl) lysine and hexitol-lysine. Free Radical Biology and Medicine 2001 31 2 175 180 2-s2.0-0035879693 10.1016/S0891-5849(01)00570-6 (Pubitemid 32607584)
16. Lüth H.-J., Ogunlade V., Kuhla B., Kientsch-Engel R., Stahl P., Webster J., Arendt T., Münch G., Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cerebral Cortex 2005 15 2 211 220 2-s2.0-12144278195 10.1093/cercor/bhh123 (Pubitemid 40111081)
17. Amicarelli F., Colafarina S., Cattani F., Cimini A., Ilio C. Di, Ceru M. P., Miranda M., Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radical Biology and Medicine 2003 35 8 856 871 2-s2.0-0141861127 10.1016/S0891-5849(03)00438-6 (Pubitemid 37211440)
18. Kikuchi S., Shinpo K., Moriwaka F., Makita Z., Miyata T., Tashiro K., Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. Journal of Neuroscience Research 1999 57 2 280 289 (Pubitemid 29300331)
19. Shinpo K., Kikuchi S., Sasaki H., Ogata A., Moriwaka F., Tashiro K., Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons. Brain Research 2000 861 1 151 159 2-s2.0-0034616101 10.1016/S0006-8993(00)02047-3 (Pubitemid 30177293)
20. Butterfield D. A., Lauderback C. M., Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β -peptide-associated free radical oxidative stress. Free Radical Biology and Medicine 2002 32 11 1050 1060 2-s2.0-0036591849 10.1016/S0891-5849(02)00794-3 (Pubitemid 34603342)
21. Cross C. E., Halliwell B., Borish E. T., Pryor W. A., Ames B. N., Saul R. L., McCord J. M., Harman D., Oxygen radicals and human disease. Davis conference. Annals of Internal Medicine 1987 107 4 526 545 2-s2.0-0023229496 (Pubitemid 17149773)
22. Markesbery W. R., Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology and Medicine 1997 23 1 134 147 2-s2.0-0030915855 10.1016/S0891-5849(96)00629-6 (Pubitemid 27217017)
23. Tarozzi A., Angeloni C., Malaguti M., Morroni F., Hrelia S., Hrelia P., Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxidative Medicine and Cellular Longevity 2013 2013 10 415078 10.1155/2013/415078
24. Abramov A. Y., Canevari L., Duchen M. R., β -amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. Journal of Neuroscience 2004 24 2 565 575 2-s2.0-1642499152 10.1523/JNEUROSCI.4042-03.2004 (Pubitemid 38112390)
25. Motori E., Puyal J., Toni N., Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance. Cell Metabolism 2013 18 6 844 859 10.1016/j.cmet.2013.11.005
26. Silva M. S., Gomes R. A., Ferreira A. E., Freire A. P., Cordeiro C., The glyoxalase pathway: the first hundred years. and beyond. The Biochemical Journal 2013 453 1 1 15 10.1042/BJ20121743
27. Nemet I., Varga-Defterdarović L., Turk Z., Methylglyoxal in food and living organisms. Molecular Nutrition and Food Research 2006 50 12 1105 1117 2-s2.0-33845916839 10.1002/mnfr.200600065 (Pubitemid 46032199)
28. Wang J., Chang T., Methylglyoxal content in drinking coffee as a cytotoxic factor. Journal of Food Science 2010 75 6 H167 H171 2-s2.0-77955795700 10.1111/j.1750-3841.2010.01658.x
29. Kalapos M. P., Where does plasma methylglyoxal originate from? Diabetes Research and Clinical Practice 2013 99 3 260 271 10.1016/j.diabres.2012.11.003
30. Vistoli G., De Maddis D., Cipak A., Zarkovic N., Carini M., Aldini G., Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radical Research 2013 47 S1 3 27 10.3109/10715762.2013.815348
31. Degen J., Hellwig M., Henle T., 1,2-dicarbonyl compounds in commonly consumed foods. Journal of Agricultural and Food Chemistry 2012 60 28 7071 7079 10.1021/jf301306g
32. Pfeifer Y. V., Haase P. T., Kroh L. W., Reactivity of thermally treated alpha-dicarbonyl compounds. Journal of Agricultural and Food Chemistry 2013 61 12 3090 3096 10.1021/jf302959k
33. Nemet I., Varga-Defterdarović L., Methylglyoxal-derived β -carbolines formed from tryptophan and its derivates in the Maillard reaction. Amino Acids 2007 32 2 291 293 2-s2.0-33846685822 10.1007/s00726-006-0337-7 (Pubitemid 46198755)
34. Kuntz S., Rudloff S., Ehl J., Bretzel R. G., Kunz C., Food derived carbonyl compounds affect basal and stimulated secretion of interleukin-6 and -8 in Caco-2 cells. European Journal of Nutrition 2009 48 8 499 503 2-s2.0-70449518173 10.1007/s00394-009-0035-9
35. Casazza J. P., Felver M. E., Veech R. L., The metabolism of acetone in rat. The Journal of Biological Chemistry 1984 259 1 231 236 2-s2.0-0021323247 (Pubitemid 14177647)
36. Cooper R. A., Metabolism of methylglyoxal in microorganisms. Annual Review of Microbiology 1984 38 49 68 2-s2.0-0021195497
37. Fujioka K., Shibamoto T., Determination of toxic carbonyl compounds in cigarette smoke. Environmental Toxicology 2006 21 1 47 54 2-s2.0-33244473082 10.1002/tox.20153 (Pubitemid 43277216)
38. Camel V., Bermond A., The use of ozone and associated oxidation processes in drinking water treatment. Water Research 1998 32 11 3208 3222 2-s2.0-0032210739 10.1016/S0043-1354(98)00130-4 (Pubitemid 28473032)
39. Fu T.-M., Jacob D. J., Wittrock F., Burrows J. P., Vrekoussis M., Henze D. K., Global budgets of atmospheric glyoxal and methylglyoxal, and implications for formation of secondary organic aerosols. Journal of Geophysical Research D 2008 113 15 2-s2.0-71949119674 10.1029/2007JD009505 D15303
40. Kalapos M. P., Methylglyoxal in living organisms-chemistry, biochemistry, toxicology and biological implications. Toxicology Letters 1999 110 3 145 175 2-s2.0-0032703938 10.1016/S0378-4274(99)00160-5 (Pubitemid 29528251)
41. Beisswenger P. J., Howell S. K., Nelson R. G., Mauer M., Szwergold B. S., α -oxoaldehyde metabolism and diabetic complications. Biochemical Society Transactions 2003 31, part 6 1358 1363 2-s2.0-0347419280
42. Kalapos M. P., Methylglyoxal and glucose metabolism: a historical perspective and future avenues for research. Drug Metabolism and Drug Interactions 2008 23 1-2 69 91 2-s2.0-43449101902 (Pubitemid 351669566)
43. Kalapos M. P., The tandem of free radicals and methylglyoxal. Chemico-Biological Interactions 2008 171 3 251 271 2-s2.0-38749130432 10.1016/j.cbi.2007.11.009
44. Cui Q., Karplus M., Catalysis and specificity in enzymes: a study of triosephosphate isomerase and comparison with methyl glyoxal synthase. Advances in Protein Chemistry 2003 66 315 372 2-s2.0-0242443649 10.1016/S0065-3233(03) 66008-0 (Pubitemid 37392319)
45. Richard J. P., Mechanism for the formation of methylglyoxal from triosephosphates. Biochemical Society Transactions 1993 21 2 549 553 2-s2.0-0027286747 (Pubitemid 23167966)
46. Cooper R. A., [104] Methylglyoxal synthase. Methods in Enzymology 1975 41 502 508 2-s2.0-0016414235 10.1016/S0076-6879(75)41106-5
47. Dhar A., Desai K., Kazachmov M., Yu P., Wu L., Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors. Metabolism: Clinical and Experimental 2008 57 9 1211 1220 2-s2.0-48849083804 10.1016/j.metabol.2008.04.014
48. Bondoc F. Y., Bao Z., Hu W.-Y., Gonzalez F. J., Wang Y., Yang C. S., Hong J.-Y., Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice. Biochemical Pharmacology 1999 58 3 461 463 2-s2.0-0032973998 10.1016/S0006-2952(99)00111-2 (Pubitemid 29281546)
49. Turk Z., Nemet I., Varga-Defteardarovic L., Car N., Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase. Diabetes and Metabolism 2006 32 2 176 180 2-s2.0-33645994831 10.1016/S1262-3636(07)70266-5
50. Jung J.-Y., Yun H. S., Lee J., Oh M.-K., Production of 1,2-propanediol from glycerol in saccharomyces cerevisiae. Journal of Microbiology and Biotechnology 2011 21 8 846 853 2-s2.0-80052280696 10.4014/jmb.1103.03009
51. Shibamoto T., Analytical methods for trace levels of reactive carbonyl compounds formed in lipid peroxidation systems. Journal of Pharmaceutical and Biomedical Analysis 2006 41 1 12 25 2-s2.0-33645063438 10.1016/j.jpba.2006.01. 047
52. 2+ in rat liver microsomes. The Biochemical Journal 1982 208 1 129 140 2-s2.0-0020365443 (Pubitemid 13215400)
53. Thornalley P. J., The glyoxalase system in health and disease. Molecular Aspects of Medicine 1993 14 4 287 371 2-s2.0-0027454552 10.1016/0098-2997(93) 90002-U
54. Lyles G. A., Chalmers J., The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochemical Pharmacology 1992 43 7 1409 1414 2-s2.0-0026603415 10.1016/0006-2952(92)90196-P
55. Bechara E. J. H., Dutra F., Cardoso V. E. S., Sartori A., Olympio K. P. K., Penatti C. A. A., Adhikari A., Assunção N. A., The dual face of endogenous α -aminoketones: pro-oxidizing metabolic weapons. Comparative Biochemistry and Physiology C 2007 146 1-2 88 110 2-s2.0-34447296740 10.1016/j.cbpc.2006.07.004 (Pubitemid 47061524)
56. Callingham B. A., Crosbie A. E., Rous B. A., Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes. Progress in Brain Research 1995 106 305 321 2-s2.0-0029562807 (Pubitemid 26027009)
57. Lyles G. A., Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. International Journal of Biochemistry and Cell Biology 1996 28 3 259 274 2-s2.0-0029869337 10.1016/1357-2725(95)00130-1 (Pubitemid 26116662)
58. Thornalley P. J., Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabolism and Drug Interactions 2008 23 1-2 125 150 2-s2.0-43449094351 (Pubitemid 351669568)
59. Thornalley P. J., Langborg A., Minhas H. S., Formation of glyoxal, methylglyoxal and 8-deoxyglucosone in the glycation of proteins by glucose. The Biochemical Journal 1999 344, part 1 109 116 2-s2.0-0033571012 10.1042/0264-6021:3440109
60. Thornalley P. J., Battah S., Ahmed N., Karachalias N., Agalou S., Babaei-Jadidi R., Dawnay A., Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. The Biochemical Journal 2003 375, part 3 581 592 2-s2.0-0242468729 10.1042/BJ20030763 (Pubitemid 37433506)
61. Ahmed N., Thornalley P. J., Dawczynski J., Franke S., Strobel J., Stein G., Haik G. M., Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Investigative Ophthalmology and Visual Science 2003 44 12 5287 5292 2-s2.0-0345282976 10.1167/iovs.03-0573 (Pubitemid 37475400)
62. Oya T., Hattori N., Mizuno Y., Miyata S., Maeda S., Osawa T., Uchida K., Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. The Journal of Biological Chemistry 1999 274 26 18492 18502 2-s2.0-0033603599 10.1074/jbc.274.26.18492 (Pubitemid 29293843)
63. Shipanova I. N., Glomb M. A., Nagaraj R. H., Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Archives of Biochemistry and Biophysics 1997 344 1 29 36 2-s2.0-0031214523 10.1006/abbi.1997.0195 (Pubitemid 27328093)
64. Frye E. B., Degenhardt T. P., Thorpe S. R., Baynes J. W., Role of the Maillard reaction in aging of tissue proteins: advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. The Journal of Biological Chemistry 1998 273 30 18714 18719 2-s2.0-0032563120 10.1074/jbc.273.30.18714 (Pubitemid 28366254)
65. Bieme K. M., Alexander Fried D., Lederer M. O., Identification and quantification of major maillard cross-links in human serum albumin and lens protein: evidence for glucosepane as the dominant compound. The Journal of Biological Chemistry 2002 277 28 24907 24915 2-s2.0-0037067723 10.1074/jbc.M202681200 (Pubitemid 34951792)
66. Lo T. W. C., Westwood M. E., McLellan A. C., Selwood T., Thornalley P. J., Binding and modification of proteins by methylglyoxal under physiological conditions: a kinetic and mechanistic study with N α -acetylarginine, N α-acetylcysteine, and N α -acetyllysine, and bovine serum albumin. The Journal of Biological Chemistry 1994 269 51 32299 32305 2-s2.0-0028605299
67. Ahmed N., Dobler D., Dean M., Thornalley P. J., Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. The Journal of Biological Chemistry 2005 280 7 5724 5732 2-s2.0-14044251043 10.1074/jbc.M410973200 (Pubitemid 40280052)
68. Kaufmann E., Boehm B. O., Süssmuth S. D., Kientsch-Engel R., Sperfeld A., Ludolph A. C., Tumani H., The advanced glycation end-product N ε -(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neuroscience Letters 2004 371 2-3 226 229 2-s2.0-7444267452 10.1016/j.neulet.2004.08.071 (Pubitemid 39440776)
69. Southern L., Williams J., Esiri M. M., Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia. BMC Neurology 2007 7, article 35 2-s2.0-36849076840 10.1186/1471-2377-7-35 (Pubitemid 350226868)
70. Krautwald M., Münch G., Advanced glycation end products as biomarkers and gerontotoxins-a basis to explore methylglyoxal-lowering agents for Alzheimer's disease? Experimental Gerontology 2010 45 10 744 751 2-s2.0-77956989586 10.1016/j.exger.2010.03.001
71. Jono T., Kimura T., Takamatsu J., Nagai R., Miyazaki K., Yuzuriha T., Kitamura T., Horiuchi S., Accumulation of imidazolone, pentosidine and N ε -(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain. Pathology International 2002 52 9 563 571 2-s2.0-0036430091 10.1046/j.1320-5463.2002.01390.x (Pubitemid 35335038)
72. Ahmed N., Ahmed U., Thornalley P. J., Hager K., Fleischer G., Münch G., Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. Journal of Neurochemistry 2005 92 2 255 263 2-s2.0-13244270042 10.1111/j.1471-4159.2004.02864.x (Pubitemid 40194017)
73. Taniguchi N., Takahashi M., Sakiyama H., Park Y. S., Asahi M., Misonou Y., Miyamoto Y., A common pathway for intracellular reactive oxygen species production by glycoxidative and nitroxidative stress in vascular endothelial cells and smooth muscle cells. Annals of the New York Academy of Sciences 2005 1043 521 528 2-s2.0-23744515185 10.1196/annals.1333.059 (Pubitemid 41123941)
74. Desai K. M., Wu L., Free radical generation by methylglyoxal in tissues. Drug Metabolism and Drug Interactions 2008 23 1-2 151 173 2-s2.0-43449126527 (Pubitemid 351669569)
75. Dmitriev L. F., Titov V. N., Lipid peroxidation in relation to ageing and the role of endogenous aldehydes in diabetes and other age-related diseases. Ageing Research Reviews 2010 9 2 200 210 2-s2.0-77949275811 10.1016/j.arr.2009. 09.004
76. Chang T., Wu L., Methylglyoxal, oxidative stress, and hypertension. Canadian Journal of Physiology and Pharmacology 2006 84 12 1229 1238 2-s2.0-34248162057 10.1139/Y06-077 (Pubitemid 46707370)
77. Dhar I., Desai K., Gallelli L., Chapter 30. Aging: drugs to eliminate methylglyoxal, a reactive glucose metabolite, and advanced glycation endproducts. Pharmacology 2012 10.5772/34337
78. Kalapos M. P., Desai K. M., Wu L., Methylglyoxal, oxidative stress, and aging. Aging and Age-Related Disorders 2010 Humana Press 149 167 Oxidative Stress in Applied Basic Research and Clinical Practice 10.1007/978-1-60761-602- 3-8
79. Huang X., Wang F., Chen W., Chen Y., Wang N., von Maltzan K., Possible link between the cognitive dysfunction associated with diabetes mellitus and the neurotoxicity of methylglyoxal. Brain Research 2012 1469 82 91 10.1016/j.brainres.2012.06.011
80. Szent-Gyorgyi A., Bioelectronics: A Study in cellular regulations, Defense, and cancer 1968 New York, NY, USA Academic Press
81. Kon H., Szent Gyorgyi A., Charge transfer between amine and carbonyl. Proceedings of the National Academy of Sciences of the United States of America 1973 70 11 3139 3140 2-s2.0-0015688182
82. Kalapos M. P., Littauer A., De Groot H., Has reactive oxygen a role in methylglyoxal toxicity? A study on cultured rat hepatocytes. Archives of Toxicology 1993 67 5 369 372 2-s2.0-0027176827 (Pubitemid 23180985)
83. Yu P. H., Wright S., Fan E. H., Lun Z.-R., Gubisne-Harberle D., Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochimica et Biophysica Acta 2003 1647 1-2 193 199 2-s2.0-0038549049 10.1016/S1570-9639(03)00101-8 (Pubitemid 38234655)
84. Johnson J. M., Halsall H. B., Heineman W. R., Redox activation of galactose oxidase: thin-layer electrochemical study. Biochemistry 1985 24 7 1579 1585 2-s2.0-0022432720
85. 2 production by phanerochaete chrysosporium. Journal of Bacteriology 1987 169 5 2195 2201 2-s2.0-0023264566 (Pubitemid 17081786)
86. 2-producing glyoxal oxidase is required for filamentous growth and pathogenicity in Ustilago maydis. Molecular Genetics and Genomics 2005 272 6 639 650 2-s2.0-15044339288 10.1007/s00438-004-1085-6 (Pubitemid 40379319)
87. Hiraku Y., Sugimoto J., Yamaguchi T., Kawanishi S., Oxidative DNA damage induced by aminoacetone, an amino acid metabolite. Archives of Biochemistry and Biophysics 1999 365 1 62 70 2-s2.0-0033134263 10.1006/abbi.1999.1161 (Pubitemid 29394250)
88. Dutra F., Knudsen F. S., Curi D., Bechara E. J. H., Aerobic oxidation of aminoacetone, a threonine catabolite: iron catalysis and coupled iron release from ferritin. Chemical Research in Toxicology 2001 14 9 1323 1329 2-s2.0-0034802987 10.1021/tx015526r (Pubitemid 32911473)
89. Vidigal C. C. C., Cilento G., Evidence for the generation of excited methylglyoxal in the myoglobin catalyzed oxidation of acetoacetate. Biochemical and Biophysical Research Communications 1975 62 2 184 190 2-s2.0-0016442581
90. Takayama K., Nakano M., Zinner K., Generation of electronic energy in the myoglobin catalyzed oxidation of acetoacetate to methylglyoxal. Archives of Biochemistry and Biophysics 1976 176 2 663 670 2-s2.0-0017109209
91. Yamaguchi T., Nakagawa K., Mutagenicity of and formation of oxygen radicals by trioses and glyoxal derivatives. Agricultural and Biological Chemistry 1983 47 11 2461 2465 2-s2.0-0021019142 (Pubitemid 14183887)
92. Thornalley P., Wolff S., Crabbe J., Stern A., The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochimica et Biophysica Acta 1984 797 2 276 287 2-s2.0-0021361665 10.1016/0304-4165(84)90131-4 (Pubitemid 14197639)
93. Thornalley P. J., Wolff S. P., Crabbe M. J., Stern A., The oxidation of oxyhaemoglobin by glyceraldehyde and other simple monosaccharides. The Biochemical Journal 1984 217 3 615 622 2-s2.0-0021348876 (Pubitemid 14186868)
94. Atkinson R., Carter W. P. L., Darnall K. R., Winer M., Pitts J. N., A smog chamber and modeling study of the gas phase NOx-air photooxidation of toluene and the cresols. International Journal of Chemical Kinetics 1980 12 11 779 836 10.1002/kin.550121102
95. Nukaya H., Inaoka Y., Ishida H., Tsuji K., Suwa Y., Wakabayashi K., Kosuge T., Modification of the amino group of guanosine by methylglyoxal and other α -ketoaldehydes in the presence of hydrogen peroxide. Chemical and Pharmaceutical Bulletin 1993 41 4 649 653 2-s2.0-0027194954 (Pubitemid 23166133)
96. Angeloni C., Turroni S., Bianchi L., Novel targets of sulforaphane in primary cardiomyocytes identified by proteomic analysis. PLoS ONE 2013 8 12 e83283 10.1371/journal.pone.0083283
97. Chang T., Wang R., Wu L., Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radical Biology and Medicine 2005 38 2 286 293 2-s2.0-10644266855 10.1016/j.freeradbiomed.2004. 10.034 (Pubitemid 39656138)
98. Ho C., Lee P.-H., Huang W.-J., Hsu Y.-C., Lin C.-L., Wang J.-Y., Methylglyoxal-induced fibronectin gene expression through ras-mediated NADPH oxidase activation in renal mesangial cells. Nephrology 2007 12 4 348 356 2-s2.0-34447542039 10.1111/j.1440-1797.2007.00809.x (Pubitemid 47075418)
99. Ward R. A., McLeish K. R., Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure? Nephrology Dialysis Transplantation 2004 19 7 1702 1707 2-s2.0-3242664216 10.1093/ndt/gfh271 (Pubitemid 38961377)
100. Nicolay J., Schneider J., Niemoeller O., Artunc F., Portero-Otin M., Haik G. Jr., Thornalley P., Schleicher E., Wieder T., Lang F., Stimulation of suicidal erythrocyte death by methylglyoxal. Cellular Physiology and Biochemistry 2006 18 4-5 223 232 2-s2.0-33845602187 10.1159/000097669 (Pubitemid 44946977)
101. Park Y. S., Koh Y. H., Takahashi M., Miyamoto Y., Suzuki K., Dohmae N., Takio K., Honke K., Taniguchi N., Identification of the binding site of methylglyoxal on gluthathione peroxidase: methylglyoxal inhibits glutathione peroxidase activity via binding to glutathione binding sites Arg 184 and 185. Free Radical Research 2003 37 2 205 211 2-s2.0-0037306962 10.1080/ 1071576021000041005 (Pubitemid 36124347)
102. Thornalley P. J., Glutathione-dependent detoxification of α -oxoaldehydes by the glyoxalase system: Involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chemico-Biological Interactions 1998 111-112 137 151 2-s2.0-4244040278 10.1016/S0009-2797(97)00157- 9 (Pubitemid 28271940)
103. Kang J. H., Modification and inactivation of human Cu,Zn-superoxide dismutase by methylglyoxal. Molecules and Cells 2003 15 2 194 199 2-s2.0-0037928722 (Pubitemid 41582923)
104. Rabbani N., Thornalley P. J., Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress. Biochemical Society Transactions 2008 36, part5 1045 1050 2-s2.0-53849092368 10.1042/BST0361045
105. Rosca M. G., Mustata T. G., Kinter M. T., Ozdemir A. M., Kern T. S., Szweda L. I., Brownlee M., Monnier V. M., Weiss M. F., Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. The American Journal of Physiology: Renal Physiology 2005 289 2 F420 F430 2-s2.0-22344442393 10.1152/ajprenal.00415.2004 (Pubitemid 41003672)
106. Du J., Suzuki H., Nagase F., Akhand A. A., Ma X.-Y., Yokoyama T., Miyata T., Nakashima I., Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process. Free Radical Biology and Medicine 2001 31 4 469 478 2-s2.0-0035882511 10.1016/S0891-5849(01) 00611-6 (Pubitemid 32728434)
107. Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D. M., Schmidt A. M., De Caterina R., Advanced glycation end products activate endothelium through signal-transduction receptor RAGE a mechanism for amplification of inflammatory responses. Circulation 2002 105 7 816 822 2-s2.0-0037133280 10.1161/hc0702.104183 (Pubitemid 34174921)
108. Chen J., Brodsky S. V., Goligorsky D. M., Hampel D. J., Li H., Gross S. S., Goligorsky M. S., Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circulation Research 2002 90 12 1290 1298 2-s2.0-0037188926 10.1161/01.RES.0000022161.42655.98 (Pubitemid 34787411)
109. Kikuchi S., Shinpo K., Takeuchi M., Yamagishi S., Makita Z., Sasaki N., Tashiro K., Glycation-a sweet tempter for neuronal death. Brain Research Reviews 2003 41 2-3 306 323 2-s2.0-0037347268 10.1016/S0165-0173(02)00273-4 (Pubitemid 36349690)
110. Wautier M.-P., Chappey O., Corda S., Stern D. M., Schmidt A. M., Wautier J.-L., Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. The American Journal of Physiology: Endocrinology and Metabolism 2001 280 5 E685 E694 2-s2.0-0034996659
111. Westwood M. E., Thornalley P. J., Induction of synthesis and secretion of interleukin 1 β in the human monocytic THP-1 cells by human serum albumins modified with methylglyoxal and advanced glycation endproducts. Immunology Letters 1996 50 1-2 17 21 2-s2.0-0029950666 10.1016/0165-2478(96)02496-0 (Pubitemid 26179995)
112. Thornalley P. J., Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cellular and Molecular Biology 1998 44 7 1013 1023 2-s2.0-0000746938
113. Bierhaus A., Chevion S., Chevion M., Hofmann M., Quehenberger P., Illmer T., Luther T., Berentshtein E., Tritschler H., Müller M., Wahl P., Ziegler R., Nawroth P. P., Advanced glycation end product-induced activation of NF- B is suppressed by α -lipoic acid in cultured endothelial cells. Diabetes 1997 46 9 1481 1490 2-s2.0-2442631329 (Pubitemid 27369087)
114. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A., Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1994 91 11 4766 4770 2-s2.0-0028363366 10.1073/pnas.91.11.4766 (Pubitemid 24177730)
115. Kimura T., Takamatsu J., Araki N., Goto M., Kondo A., Miyakawa T., Horiuchi S., Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease? NeuroReport 1995 6 6 866 868 2-s2.0-0028959714
116. Ko S.-Y., Lin Y.-P., Lin Y.-S., Chang S.-S., Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species. Free Radical Biology and Medicine 2010 49 3 474 480 2-s2.0-77954142794 10.1016/j.freeradbiomed.2010.05.005
117. Li X. H., Du L. L., Cheng X. S., Glycation exacerbates the neuronal toxicity of beta-amyloid. Cell Death and Disease 2013 4, article e673 10.1038/cddis.2013.180
118. Schipper H. M., Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiology of Aging 2011 32 5 778 790 2-s2.0-79954605836 10.1016/j.neurobiolaging.2009.04.021
119. Bu G., Apolipoprotein e and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nature Reviews Neuroscience 2009 10 5 333 344 2-s2.0-67349270965 10.1038/nrn2620
120. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K., Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Research 1991 541 1 163 166 2-s2.0-0025971426 10.1016/0006-8993(91)91092-F
121. Kok E., Haikonen S., Luoto T., Huhtala H., Goebeler S., Haapasalo H., Karhunen P. J., Apolipoprotein E-dependent accumulation of alzheimer disease-related lesions begins in middle age. Annals of Neurology 2009 65 6 650 657 2-s2.0-67650094927 10.1002/ana.21696
122. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinisto L., Halonen P., Kontula K., Apolipoprotein E, dementia, and cortical deposition of β -amyloid protein. The New England Journal of Medicine 1995 333 19 1242 1247 2-s2.0-0028841027 10.1056/NEJM199511093331902
123. Li Y. M., Dickson D. W., Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease. Neuroscience Letters 1997 226 3 155 158 2-s2.0-0030908734 10.1016/S0304-3940(97)00266-8 (Pubitemid 27201967)
124. Münch G., Westcott B., Menini T., Gugliucci A., Advanced glycation endproducts and their pathogenic roles in neurological disorders. Amino Acids 2012 42 4 1221 1236 2-s2.0-77957732720 10.1007/s00726-010-0777-y
125. Li J. J., Surini M., Catsicas S., Kawashima E., Bouras C., Age-dependent accumulation of advanced glycosylation end products in human neurons. Neurobiology of Aging 1995 16 1 69 76 2-s2.0-0028812472 10.1016/0197-4580(95) 80009-G
126. Wong A., Lüth H.-J., Deuther-Conrad W., Dukic-Stefanovic S., Gasic-Milenkovic J., Arendt T., Münch G., Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Research 2001 920 1-2 32 40 2-s2.0-0035976590 10.1016/S0006-8993(01)02872-4 (Pubitemid 33086777)
127. Prakash Reddy V., Obrenovich M. E., Atwood C. S., Perry G., Smith M. A., Involvement of Maillard reactions in Alzheimer disease. Neurotoxicity Research 2002 4 3 191 209 2-s2.0-0036080646 10.1080/1029840290007321 (Pubitemid 34679370)
128. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stern D., Sayre L. M., Monnier V. M., Perry G., Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proceedings of the National Academy of Sciences of the United States of America 1994 91 12 5710 5714 2-s2.0-0028233977 10.1073/pnas.91.12.5710 (Pubitemid 24174398)
129. Shuvaev V. V., Laffont I., Serot J.-M., Fujii J., Taniguchi N., Siest G., Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiology of Aging 2001 22 3 397 402 2-s2.0-0034992635 10.1016/S0197-4580(00) 00253-0 (Pubitemid 32510910)
130. Bär K. J., Franke S., Wenda B., Müller S., Kientsch-Engel R., Stein G., Sauer H., Pentosidine and N ε -(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiology of Aging 2003 24 2 333
131. Mucke L., Neuroscience: Alzheimer's disease. Nature 2009 461 7266 895 897 2-s2.0-70350075694 10.1038/461895a
132. Beeri M. S., Moshier E., Schmeidler J., Godbold J., Uribarri J., Reddy S., Sano M., Grossman H. T., Cai W., Vlassara H., Silverman J. M., Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mechanisms of Ageing and Development 2011 132 11-12 583 587 2-s2.0-84855887867 10.1016/j.mad.2011.10.007
133. Lovell M. A., Xie C., Markesbery W. R., Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiology of Aging 2001 22 2 187 194 2-s2.0-0035112495 10.1016/S0197-4580(00) 00235-9 (Pubitemid 32162967)
134. Andersen J. K., Oxidative stress in neurodegeneration: cause or consequence? Nature Medicine 2004 5 S18 S25 2-s2.0-3142514196 10.1038/nrn1434 (Pubitemid 38901863)
135. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C. S., Petersen R. B., Smith M. A., Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2001 60 8 759 767 2-s2.0-0034923434 (Pubitemid 32678256)
136. Swerdlow R. H., Brain aging, Alzheimer's disease, and mitochondria. Biochimica et Biophysica Acta 2011 1812 12 1630 1639 2-s2.0-80053892506 10.1016/j.bbadis.2011.08.012
137. Good P. F., Werner P., Hsu A., Olanow C. W., Perl D. P., Evidence for neuronal oxidative damage in Alzheimer's disease. The American Journal of Pathology 1996 149 1 21 28 2-s2.0-0029902166 (Pubitemid 26230974)
138. de Arriba S. G., Stuchbury G., Yarin J., Burnell J., Loske C., Münch G., Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells-protection by carbonyl scavengers. Neurobiology of Aging 2007 28 7 1044 1050 2-s2.0-34247359088 10.1016/j.neurobiolaging.2006.05.007 (Pubitemid 46635909)
139. Huang S.-M., Chuang H.-C., Wu C.-H., Yen G.-C., Cytoprotective effects of phenolic acids on methylglyoxal-induced apoptosis in Neuro-2A cells. Molecular Nutrition and Food Research 2008 52 8 940 949 2-s2.0-54549094837 10.1002/mnfr.200700360
140. Chen Y.-J., Huang X.-B., Li Z.-X., Yin L.-L., Chen W.-Q., Li L., Tenuigenin protects cultured hippocampal neurons against methylglyoxal-induced neurotoxicity. European Journal of Pharmacology 2010 645 1-3 1 8 2-s2.0-77956186680 10.1016/j.ejphar.2010.06.034
141. Yin Q. Q., Dong C. F., Dong S. Q., AGEs induce cell death via oxidative and endoplasmic reticulum stresses in both human SH-SY5Y neuroblastoma cells and rat cortical neurons. Cellular and Molecular Neurobiology 2012 32 8 1299 1309 10.1007/s10571-012-9856-9
142. Liu F., Liang Z., Gong C. X., Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease. Panminerva Medica 2006 48 2 97 108 2-s2.0-33750535186 (Pubitemid 44671265)
143. Iqbal K., Liu F., Gong C.-X., del Alonso A. C., Grundke-Iqbal I., Mechanisms of tau-induced neurodegeneration. Acta Neuropathologica 2009 118 1 53 69 2-s2.0-67349142329 10.1007/s00401-009-0486-3
144. Planel E., Miyasaka T., Launey T., Chui D.-H., Tanemura K., Sato S., Murayama O., Ishiguro K., Tatebayashi Y., Takashima A., Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. Journal of Neuroscience 2004 24 10 2401 2411 2-s2.0-12144289492 10.1523/JNEUROSCI.5561-03.2004 (Pubitemid 38327953)
145. Hu M., Waring J. F., Gopalakrishnan M., Li J., Role of GSK-3 β activation and α 7 nAChRs in A β 1-42-induced tau phosphorylation in PC12 cells. Journal of Neurochemistry 2008 106 3 1371 1377 2-s2.0-48249087675 10.1111/j.1471-4159.2008.05483.x
146. Gong C. X., Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 1994 61 4 765 772 2-s2.0-0028064431 10.1016/0306-4522(94)90400-6 (Pubitemid 24291919)
147. Wang J.-Z., Gong C.-X., Zaidi T., Grundke-Iqbal I., Iqbal K., Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. The Journal of Biological Chemistry 1995 270 9 4854 4860 2-s2.0-0028902487 10.1074/jbc.270.9.4854
148. Li X. H., Xie J. Z., Jiang X., Methylglyoxal induces tau hyperphosphorylation via promoting AGEs formation. NeuroMolecular Medicine 2012 14 4 338 348 10.1007/s12017-012-8191-0
149. Smith M. A., Rudnicka-Nawrot M., Richey P. L., Praprotnik D., Mulvihill P., Miller C. A., Sayre L. M., Perry G., Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. Journal of Neurochemistry 1995 64 6 2660 2666 2-s2.0-0029007478
150. Cras P., Smith M. A., Richey P. L., Siedlak S. L., Mulvihill P., Perry G., Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross linking in Alzheimer disease. Acta Neuropathologica 1995 89 4 291 295 2-s2.0-0028918383 10.1007/s004010050249
151. Kuhla B., Haase C., Flach K., Luth H. J., Arendt T., Munch G., Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem 2007 282 10 6984 6991 10.1074/jbc.M609521200 (Pubitemid 47093635)
152. Lin M. T., Beal M. F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006 443 7113 787 795 2-s2.0-33750347347 10.1038/nature05292 (Pubitemid 44622683)
153. Praticò D., Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends in Pharmacological Sciences 2008 29 12 609 615 2-s2.0-56349145099 10.1016/j.tips.2008.09.001
154. Zhu X., Lee H.-G., Raina A. K., Perry G., Smith M. A., The role of mitogen-activated protein kinase pathways in Alzheimer's disease. NeuroSignals 2002 11 5 270 281 2-s2.0-0036770144 10.1159/000067426 (Pubitemid 37494394)
155. Chiarini A., Dal Pra I., Marconi M., Chakravarthy B., Whitfield J. F., Armato U., Calcium-sensing receptor (CaSR) in human brain's pathophysiology: Roles in late-onset Alzheimer's disease (LOAD). Current Pharmaceutical Biotechnology 2009 10 3 317 326 2-s2.0-65949085175 10.2174/138920109787847501
156. Hashimoto Y., Tsuji O., Niikura T., Yamagishi Y., Ishizaka M., Kawasumi M., Chiba T., Kanekura K., Yamada M., Tsukamoto E., Kouyama K., Terashita K., Aiso S., Lint A., Nishimoto I., Involvement of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death. Journal of Neurochemistry 2003 84 4 864 877 2-s2.0-20244361899 10.1046/j.1471-4159.2003. 01585.x (Pubitemid 36176943)
157. Marques C. A., Keil U., Bonert A., Steiner B., Haass C., Müller W. E., Eckert A., Neurotoxic mechanisms caused by the alzheimer's disease-linked Swedish amyloid precursor protein. Mutation oxidative stress, caspases, and the JNK pathway. The Journal of Biological Chemistry 2003 278 30 28294 28302 2-s2.0-0042847291 10.1074/jbc.M212265200 (Pubitemid 36900031)
158. Puig B., Gómez-Isla T., Ribé E., Cuadrado M., Torrejon-Escribano B., Dalfó E., Ferrer I., Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding β A plaques in APP Tg2576 mice. Neuropathology and Applied Neurobiology 2004 30 5 491 502 2-s2.0-7044284920 10.1111/j.1365-2990.2004.00569.x (Pubitemid 39423036)
159. Tamagno E., Parola M., Bardini P., Piccini A., Borghi R., Guglielmotto M., Santoro G., Davit A., Danni O., Smith M. A., Perry G., Tabaton M., β -site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. Journal of Neurochemistry 2005 92 3 628 636 2-s2.0-19944433845 10.1111/j.1471-4159.2004.02895.x (Pubitemid 40189465)
160. Shen C., Chen Y., Liu H., Zhang K., Zhang T., Lin A., Jing N., Hydrogen peroxide promotes A β production through JNK-dependent activation of γ -secretase. The Journal of Biological Chemistry 2008 283 25 17721 17730 2-s2.0-47749147258 10.1074/jbc.M800013200
161. Colombo A., Bastone A., Ploia C., Sclip A., Salmona M., Forloni G., Borsello T., JNK regulates APP cleavage and degradation in a model of Alzheimer's disease. Neurobiology of Disease 2009 33 3 518 525 2-s2.0-60849105665 10.1016/j.nbd.2008.12.014
162. Muresan Z., Muresan V., The amyloid- β precursor protein is phosphorylated via distinct pathways during differentiation, mitosis, stress, and degeneration. Molecular Biology of the Cell 2007 18 10 3835 3844 2-s2.0-34948814540 10.1091/mbc.E06-07-0625 (Pubitemid 47519477)
163. Fan X., Subramaniam R., Weiss M. F., Monnier V. M., Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor B and intracellular reactive oxygen species formation. Archives of Biochemistry and Biophysics 2003 409 2 274 286 2-s2.0-0037440425 10.1016/S0003-9861(02)00599- 4 (Pubitemid 36259595)
164. Pal A., Bhattacharya I., Bhattacharya K., Mandal C., Ray M., Methylglyoxal induced activation of murine peritoneal macrophages and surface markers of T lymphocytes in Sarcoma-180 bearing mice: Involvement of MAP kinase, NF- β signal transduction pathway. Molecular Immunology 2009 46 10 2039 2044 2-s2.0-67349099444 10.1016/j.molimm.2009.03.014
165. Huang S.-M., Hsu C.-L., Chuang H.-C., Shih P.-H., Wu C.-H., Yen G.-C., Inhibitory effect of vanillic acid on methylglyoxal-mediated glycation in apoptotic Neuro-2A cells. NeuroToxicology 2008 29 6 1016 1022 2-s2.0-56249128564 10.1016/j.neuro.2008.07.002
166. Heimfarth L., Loureiro S. O., Pierozan P., Methylglyoxal-induced cytotoxicity in neonatal rat brain: a role for oxidative stress and MAP kinases. Metabolic Brain Disease 2013 28 3 429 438 10.1007/s11011-013-9379-1
167. Matafome P., Sena C., Seica R., Methylglyoxal, obesity, and diabetes. Endocrine 2013 43 3 472 484 10.1007/s12020-012-9795-8